A Phase IV, Multicenter, Cross-Sectional Study to Evaluate the I50L Substitution Among Subjects Experiencing Virologic Failure on a HAART Regimen Containing Atazanavir (ATV).
Phase of Trial: Phase IV
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Atazanavir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 13 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Nov 2007 The expected completion date for this trial is now 1 Sep 2009.
- 13 Feb 2006 New trial record.